You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
dTAGV-1 hydrochloride New
Biological Activity for dTAGV-1 hydrochloride
dTAGV-1 hydrochloride is a hydrochloride salt of dTAGV-1 (Cat. No. 6914). Suitable for use in vivo. Following ip administration of 10 mg/kg in mice: T½ = 4.43 h; Cmax = 2123 ng mL-1; AUCinf = 18517 hr*ng mL-1 and CL = 9.05 mL min-1 kg-1
Negative control dTAGV-1-NEG (Cat. No. 6915) also available.
Important: It is recommended that DMSO stock solutions of this compound are made and used on the same day and are not subjected to freeze/thaw.
Sold under license from Dana-Farber Cancer Institute
Technical Data for dTAGV-1 hydrochloride
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for dTAGV-1 hydrochloride
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for dTAGV-1 hydrochloride
The following data is based on the product molecular weight 1284.01. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||0.78 mL||3.89 mL||7.79 mL|
|5 mM||0.16 mL||0.78 mL||1.56 mL|
|10 mM||0.08 mL||0.39 mL||0.78 mL|
|50 mM||0.02 mL||0.08 mL||0.16 mL|
Product Datasheets for dTAGV-1 hydrochloride
References for dTAGV-1 hydrochloride
References are publications that support the biological activity of the product.
Nabet et al (2020) Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules. Nat.Commun. 11 4687 PMID: 32948771
If you know of a relevant reference for dTAGV-1 hydrochloride, please let us know.
View Related Products by Target
Keywords: dTAGV-1 hydrochloride, dTAGV-1 hydrochloride supplier, dTAGVHL1, hydrochloride, salt, HCl, degraders, degrades, targeted, protein, degradation, FKBP12F36V, fusion, mutant, PROTAC, VHL, von, Hippel, Lindau, TPD, in, vivo, active, TAG, Degradation, Platform, 7374, Tocris Bioscience
Citations for dTAGV-1 hydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for dTAGV-1 hydrochloride. Do you know of a great paper that uses dTAGV-1 hydrochloride from Tocris? Please let us know.
Reviews for dTAGV-1 hydrochloride
There are currently no reviews for this product. Be the first to review dTAGV-1 hydrochloride and earn rewards!
Have you used dTAGV-1 hydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Targeted Protein Degradation Research Product Guide
This brochure highlights the tools and services available from Bio-Techne to support Targeted Protein Degradation research, including:
- Active Degraders
- Degrader Building Blocks
- Custom Degrader Services
- UPS Proteins and Assays
- Assays for Protein Degradation
Targeted Protein Degradation Poster
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia